Bextra, also from Pfizer, hasn't been tested as long, but so far the data look good.
From the time.com
Bextra officially hits the market in the second week of April.
From the businessweek.com
Bextra was taken off the market because of safety concerns.
From the voanews.com
Bextra, which was removed from the market in 2005 over safety concerns, was one of four drugs covered by the charges.
From the businessweek.com
Bextra, for instance, was approved for arthritis, but Pfizer promoted it for acute pain and surgical pain, and in dosages above the approved maximum.
From the thenewstribune.com
More examples
Valdecoxib: a Cox-2 inhibitor (trade name Bextra) that relieves pain and inflammation without harming the digestive tract
Valdecoxib is a non-steroidal anti-inflammatory drug (NSAID) used in the treatment of osteoarthritis, rheumatoid arthritis, and painful menstruation and menstrual symptoms. It is a cyclooxygenase-2 selective inhibitor.